Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones

Eighteen (3R) and (3R,4R)-N-phenyl-, N-phenylalkyl and N-arylsuccinimides were prepared with high enantioselectivity by biotransformation of maleimides with A. fumigatus. This environmentally friendly, clean and economical procedure was performed by the whole-cell fungal bioconversion methodology. T...

Full description

Bibliographic Details
Main Authors: Susana Zacchino, Agustina Postigo, Maximiliano Sortino
Format: Article
Language:English
Published: MDPI AG 2013-05-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/18/5/5669
id doaj-c6ef077f971b4b5692f6b3d30bcbc92a
record_format Article
spelling doaj-c6ef077f971b4b5692f6b3d30bcbc92a2020-11-24T22:23:52ZengMDPI AGMolecules1420-30492013-05-011855669568310.3390/molecules18055669Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic OnesSusana ZacchinoAgustina PostigoMaximiliano SortinoEighteen (3R) and (3R,4R)-N-phenyl-, N-phenylalkyl and N-arylsuccinimides were prepared with high enantioselectivity by biotransformation of maleimides with A. fumigatus. This environmentally friendly, clean and economical procedure was performed by the whole-cell fungal bioconversion methodology. Their corresponding eighteen racemic succinimides were prepared instead by synthetic methods. Both, the racemic and the chiral succinimides were tested simultaneously by the microbroth dilution method of CLSI against a panel of human opportunistic pathogenic fungi of clinical importance. Chiral succinimides showed higher antifungal activity than the corresponding racemic ones and the differences in activity were established by statistical methods. The bottlenecks for developing chiral drugs are how to obtain them through a low-cost procedure and with high enantiomeric excess. Results presented here accomplish both these objectives, opening an avenue for the development of asymmetric succinimides as new antifungal drugs for pharmaceutical use.http://www.mdpi.com/1420-3049/18/5/5669biotransformationAspergillus fumigatusenantioselective reductionenhanced antifungal activitychiral succinimidesmethylated succinimides
collection DOAJ
language English
format Article
sources DOAJ
author Susana Zacchino
Agustina Postigo
Maximiliano Sortino
spellingShingle Susana Zacchino
Agustina Postigo
Maximiliano Sortino
Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
Molecules
biotransformation
Aspergillus fumigatus
enantioselective reduction
enhanced antifungal activity
chiral succinimides
methylated succinimides
author_facet Susana Zacchino
Agustina Postigo
Maximiliano Sortino
author_sort Susana Zacchino
title Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
title_short Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
title_full Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
title_fullStr Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
title_full_unstemmed Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones
title_sort effects of chirality on the antifungal potency of methylated succinimides obtained by aspergillus fumigatus biotransformations. comparison with racemic ones
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2013-05-01
description Eighteen (3R) and (3R,4R)-N-phenyl-, N-phenylalkyl and N-arylsuccinimides were prepared with high enantioselectivity by biotransformation of maleimides with A. fumigatus. This environmentally friendly, clean and economical procedure was performed by the whole-cell fungal bioconversion methodology. Their corresponding eighteen racemic succinimides were prepared instead by synthetic methods. Both, the racemic and the chiral succinimides were tested simultaneously by the microbroth dilution method of CLSI against a panel of human opportunistic pathogenic fungi of clinical importance. Chiral succinimides showed higher antifungal activity than the corresponding racemic ones and the differences in activity were established by statistical methods. The bottlenecks for developing chiral drugs are how to obtain them through a low-cost procedure and with high enantiomeric excess. Results presented here accomplish both these objectives, opening an avenue for the development of asymmetric succinimides as new antifungal drugs for pharmaceutical use.
topic biotransformation
Aspergillus fumigatus
enantioselective reduction
enhanced antifungal activity
chiral succinimides
methylated succinimides
url http://www.mdpi.com/1420-3049/18/5/5669
work_keys_str_mv AT susanazacchino effectsofchiralityontheantifungalpotencyofmethylatedsuccinimidesobtainedbyaspergillusfumigatusbiotransformationscomparisonwithracemicones
AT agustinapostigo effectsofchiralityontheantifungalpotencyofmethylatedsuccinimidesobtainedbyaspergillusfumigatusbiotransformationscomparisonwithracemicones
AT maximilianosortino effectsofchiralityontheantifungalpotencyofmethylatedsuccinimidesobtainedbyaspergillusfumigatusbiotransformationscomparisonwithracemicones
_version_ 1725763575464591360